🇺🇸 FDA
Pipeline program

sequential combined AVS

SCOPE PA

Unknown other active

Quick answer

sequential combined AVS for Primary Aldosteronism is a Unknown program (other) at Yang Xiaotian with 1 ClinicalTrials.gov record(s).

Program details

Company
Yang Xiaotian
Indication
Primary Aldosteronism
Phase
Unknown
Modality
other
Status
active

Clinical trials